Diverse patient trajectories during cytotoxic chemotherapy: Capturing longitudinal patient‐reported outcomes
Abstract Background High‐value cancer care balances effective treatment with preservation of quality of life. Chemotherapy is known to affect patients’ physical and psychological well‐being negatively. Patient‐reported outcomes (PROs) provide a means to monitor declines in a patients’ well‐being dur...
Main Authors: | Amee D. Azad, Melih Yilmaz, Selen Bozkurt, James D. Brooks, Douglas W. Blayney, Tina Hernandez‐Boussard |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4124 |
Similar Items
-
Two-item PROMIS® global physical and mental health scales
by: Ron D. Hays, et al.
Published: (2017-09-01) -
Dutch reference values for the Patient-Reported Outcomes Measurement Information System Scale v1.2 - Global Health (PROMIS-GH)
by: Ellen B. M. Elsman, et al.
Published: (2021-05-01) -
Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)
by: Peipert JD, et al.
Published: (2020-06-01) -
Profiles of patients’ self-reported health after acute stroke
by: D. Leander Rimmele, et al.
Published: (2021-08-01) -
The Relationship between Dialysis Metrics and Patient-Reported Cognition, Fatigue, and Physical Function
by: Daniel A. Sturgill, et al.
Published: (2020-07-01)